Asset Details
Do you wish to reserve the book?
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Do you wish to request the book?
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Trial of Roflumilast Cream for Chronic Plaque Psoriasis
2020
Overview
A cream formulation of the phosphodiesterase type 4 inhibitor roflumilast, in two concentrations, led to higher percentages of patients with clearance or near-clearance of psoriatic lesions at 6 weeks than placebo. Difficult-to-treat intertriginous areas also improved as compared with placebo.
Publisher
Massachusetts Medical Society
Subject
/ Adult
/ Aminopyridines - administration & dosage
/ Aminopyridines - adverse effects
/ Benzamides - administration & dosage
/ Benzamides - adverse effects
/ Cyclopropanes - administration & dosage
/ Cyclopropanes - adverse effects
/ Drug Administration Schedule
/ Erythema
/ Female
/ Humans
/ Male
/ Patients
/ Phosphodiesterase 4 Inhibitors - administration & dosage
/ Phosphodiesterase 4 Inhibitors - adverse effects
/ Skin
